课题基金 / 基金详情

Self-Calibrating Biosensor Array for Rapid Point-of-care Diagnosis

Self-Calibrating Biosensor Array for Rapid Point-of-care Diagnosis
用于快速护理点诊断的自校准生物传感器阵列
批准号:
7108429
负责人:
Judith L. Erb
金额:
$20.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-15 至 2008-05-14

项目摘要

项目成果

Judith L. Erb的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): While routine point-of-care blood chemistry measurements can now be performed in clinical settings, quantitative high-sensitivity immunoassay measurements cannot. Thus, low-level serum markers for a variety of life-threatening conditions, such as sepsis, cannot be performed at the point of care. IA Inc.'s immunosensors possess the requisite speed and sensitivity needed to bring immunoassay to the point-of- care (POC), but lack the internal calibration and multiplexing features needed for measuring a panel of markers with the inter-sensor reproducibility required for clinical assays. The goal of this project is to extend IA, Inc's biosensor technology from the research environment into clinical settings by developing a self-calibrating, multi-analyte biosensor system which rapidly and accurately measures panels of low concentration disease markers in serum. The technology platform will be adaptable for rapid measurement of any blood analyte that currently requires more time-consuming immunoassay procedures. This project will focus on developing the two features that must be added to the existing technology platform in order to provide a point-of-care panel: self-calibration of sensors and multi-analyte capability. Phase II will provide a panel of inflammatory markers, such as cytokines, which are useful for diagnosis of life-threatening conditions such as sepsis and heart failure. By improving the speed with which clinical staff can make diagnosis, earlier treatment will reduce patient morbidity and mortality as well as the high cost incurred by more advanced disease progression. The Phase I Specific Aims include: 1) Develop inter-sensor calibration methods for data normalization; 2) Develop an instrument to measure 4-6 fluorescent emissions; 3) Perform calibrated simultaneous assay of 2 analytes; 4) Evaluate a universal sensor surface for use in antibody-based assays. The use of quantum dots for achieving calibration and multiplexing will be explored.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A biosensor to detect ERE-binding proteins in cancer
  • 批准号:
    6832976
  • 项目类别:
  • 资助金额:
    $11.36万
  • 财政年份:
    2004
  • 负责人:
    Judith L. Erb
  • 依托单位:
Biosensor for Screening Specific Interactions with AhR
  • 批准号:
    6786886
  • 项目类别:
  • 资助金额:
    $43.81万
  • 财政年份:
    2001
  • 负责人:
    Judith L. Erb
  • 依托单位:
Biosensor for Screening Specific Interactions with AhR
  • 批准号:
    6893763
  • 项目类别:
  • 资助金额:
    $36.48万
  • 财政年份:
    2001
  • 负责人:
    Judith L. Erb
  • 依托单位:
Biosensor for Screening Specific Interactions with AhR
  • 批准号:
    7066606
  • 项目类别:
  • 资助金额:
    $23.13万
  • 财政年份:
    2001
  • 负责人:
    Judith L. Erb
  • 依托单位:
国内基金
海外基金
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
  • 批准号:
    82371144
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    汪雪玲
  • 依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
KLK10调控胶质—血管耦合与对话促缺血性卒中后血脑屏障修复的机制
  • 批准号:
    82371465
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李龙宣
  • 依托单位:
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
  • 批准号:
    82370820
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王天歌
  • 依托单位: